Correlation Between Dyadic International and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on Dyadic International and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Maravai Lifesciences.
Diversification Opportunities for Dyadic International and Maravai Lifesciences
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dyadic and Maravai is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of Dyadic International i.e., Dyadic International and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between Dyadic International and Maravai Lifesciences
Given the investment horizon of 90 days Dyadic International is expected to generate 0.9 times more return on investment than Maravai Lifesciences. However, Dyadic International is 1.11 times less risky than Maravai Lifesciences. It trades about 0.1 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.06 per unit of risk. If you would invest 124.00 in Dyadic International on September 12, 2024 and sell it today you would earn a total of 35.00 from holding Dyadic International or generate 28.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. Maravai Lifesciences Holdings
Performance |
Timeline |
Dyadic International |
Maravai Lifesciences |
Dyadic International and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Maravai Lifesciences
The main advantage of trading using opposite Dyadic International and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |